# Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

> **NCT06774079** · PHASE4 · RECRUITING · sponsor: **University of Miami** · enrollment: 24 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Tirzepatide
- **BEHAVIORAL:** Mediterranean diet

## Key facts

- **NCT ID:** NCT06774079
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-05
- **Primary completion:** 2027-03-05
- **Final completion:** 2027-03-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06774079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06774079, "Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06774079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*